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Abstract
The evolutionary implications of recombination in HIV remain not fully understood. A plausible effect could be an
enhancement of immune escape from cytotoxic T lymphocytes (CTLs). In order to test this hypothesis, we constructed a
population dynamic model of immune escape in HIV and examined the viral-immune dynamics with and without
recombination. Our model shows that recombination (i) increases the genetic diversity of the viral population, (ii)
accelerates the emergence of escape mutations with and without compensatory mutations, and (iii) accelerates the
acquisition of immune escape mutations in the early stage of viral infection. We see a particularly strong impact of
recombination in systems with broad, non-immunodominant CTL responses. Overall, our study argues for the importance of
recombination in HIV in allowing the virus to adapt to changing selective pressures as imposed by the immune system and
shows that the effect of recombination depends on the immunodominance pattern of effector T cell responses.
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Introduction
Human immunodeficiency virus (HIV) frequently undergoes
recombination [1–3]. The high recombination rate is the
consequence of both a high switching rate of reverse transcriptase
between the two viral RNA strands during proviral synthesis [4–7]
as well as of the large fraction of infected cells that harbour more
than one provirus [8–10] (see [1] for review). Thus, when two non-
identical virions infect the same cell, RNA from two different
viruses can be packaged into a new virion, and upon a subsequent
infection, a crossover event between the two RNA strands can
result in E ˆrecombination of the genetic material (see Fig. 1A). The
evolutionary implications of recombination have been, to some
extent, addressed in the context of the evolution of anti-retroviral
resistance in HIV [11–16]. However, the effect of recombination
in HIV on coevolutionary dynamics between the virus and the
immune system has, to the best of our knowledge, not been
addressed.
HIV is known to evade the immune control, for example by
escaping from the recognition by cytotoxic T lymphocytes (CTLs).
These CTLs recognize and kill cells that display fragments of viral
peptides on their surface. More specifically, proteins produced by
the virus inside an infected cell are processed by the host cell
machinery into antigenic peptides, and loaded onto MHC class I
molecules. The resulting MHC:peptide complexes are then
presented on the surface of the cell such that the host’s CTLs,
which scan the MHC:peptide complexes, can recognize and
destroy the infected cells. Viruses can evade the immune response,
and studies of HIV-1 and SIV infections have shown selection of
CTL escape variants during both primary and chronic infections
[17–20]. The escape is mediated by the ability of the virus to alter
the presented peptide sequences (see Fig. 1B). The mutated
proteins then become invisible to the antigen-presenting machin-
ery (e.g. TAP or proteasome), dissociate from the MHC molecule,
or become unrecognisable to the effector T cell receptors [21,22].
On the other hand, escape mutations typically come at a cost to
the virus by decreasing the viral replicative capacity [23,24],
although compensatory mutations which partially restore the
fitness can emerge [25,26] (see also Fig. 1C). Thus, HIV can
efficiently escape the selective pressure of the immune system.
The immune escape dynamics in HIV can generate an
environment which is beneficial for recombination. When the
immune system generates immune responses against frequent virus
strains, a strong selective pressure arises which leads to the escape
of the virus. The immune system in turn produces novel responses
that can recognize the escape variants and lead to further escape.
The resulting coevolutionary arms race between the virus and the
immune system resembles the so-called Red Queen dynamics
between hosts and parasites, where recombination has been shown
to play an important role [27–29]. In such a scenario, parasites
adapt to infect frequent host genotypes, which gives rare host
genotypes a selective advantage. Under these conditions recom-
bination can give the host an edge in the arms race with the
parasite by rapidly generating resistant genotypes. Thus in terms
of the classical Red Queen terminology, HIV plays the role of the
‘‘host’’ and the immune system plays the role of the ‘‘parasite’’.
Given the parallel between host-parasite coevolution and virus/
immune-system dynamics, it is plausible that recombination may,
under appropriate conditions, help the virus to escape from the
immune system.
I nt h i ss t u d y ,w ee x a m i n et h er o l eo fr e c o m b i n a t i o nf o r
immune escape of HIV by using a population dynamic model of
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escape in the virus in the early stage of infection. We also find
that the CTL hierarchy is of vital importance to viral/immune
coevolution as well as viral recombination. In particular, we find
that the immunodominance pattern of the CTL response
strongly affects the mean number of escapes in the virus as
well as the impact of recombination. Furthermore, we
determine which parameters increase or decrease the impact
of viral recombination on the immune escape, and discuss in
which situations genetic shuffling could contribute to the viral
immune escape as well as to adaptation of HIV to the host in
general.
Methods
General construction of the model
Mathematical models have proved an excellent tool for studying
complex viral dynamics in vivo [30,31] as well as investigating
population genetic and dynamic consequences of recombination
[32]. Thus, in order to examine the impact of recombination on
the viral immune escape we consider a population dynamic model
which is an extension of a standard HIV dynamics model [33–35].
The model mimics the interaction of HIV with the immune system
by taking into account some basic properties of the coevolutionary
dynamics between the virus and the immune system. The model
can be expressed by the following set of ordinary differential
equations:
dT
dt
~l{dTT{
Pm
i~1 biTIi
1zTz
Pm
i~1 Ii
,
dIi
dt
~
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Figure 1. The model of recombination in HIV. Panel A: Recombination in HIV occurs in virions that contain two non-identical copies of RNA.
During reverse transcription, one or more crossover events between the two strands can take place and result in recombination. Panel B: Immune
escape of the infecting virus is modelled by assuming that n of the epitopes presented on the surface of infected cells are recognised by the CD8+ T
cells. The figure shows a situation for n~3 and an infected cell i, which contains two epitopes recognised by the immune system (a~1,3) and one
epitope that escapes the surveillance of the effector T cells (a~2). Panel C: Escape from immune recognition comes at a fitness cost for the virus, and
thus we assume that an escape mutation impairs the reproductive capacity of the pathogen (blue bar). A compensatory mutation partially restores
the fitness cost (green bar). In the absence of the escape mutation, the compensatory mutation not only decreases the replicative capacity of the
virus but also does not confer immune-resistance (yellow bar).
doi:10.1371/journal.pone.0016052.g001
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Three populations of cells are considered: susceptible naive
CD4+ T cells (T), infected CD4+ T cells (I), and effector CD8+ T
cells or CTLs (E). Naive target cells, T, are produced at a constant
rate l, and die at a rate dT. They can become infected by any of m
distinct viral strains in the population. A naive T cell infected by a
virus strain i becomes an infected cell of type Ii. The virus is
assumed to be in quasi-steady state [36], which implies that free
virus is, to a good approximation, proportional to the infected cells
at all times. The transmission rate of an infected CD4+ cell of type
Ii is then defined as bi~bfi, where b denotes the transmission rate
by cells infected with a wild-type strain and fi denotes the relative
reproductive fitness of the virus strain i (which implies that fwt~1).
An infected cell displays n distinct types of MHC:peptide
complexes, all of which are recognized at the beginning of
infection by effector cells (CTL of type Ea recognizes an epitope a).
Mutations at these epitopes can lead to escape from recognition by
CTLs and here we focus solely on those mutations that result in a
complete lack of recognition by the immune system. Whether the
clone a recognizes the viral strain i is defined in a binary
interaction matrix aia, where 1 denotes recognition and 0 denotes
escape (see Fig. 1B). We assume that each viral epitope consists of
two loci: an escape locus and a compensatory locus. A single
mutation in either locus leads to an impairment of the replicative
capacity respective to the wild-type (each fitness value is randomly
drawn from a uniform distribution between fmin and 1), while a
double mutation partially restores it (uniformly drawn from the
higher fitness of the two loci and 1; see Fig. 1C). The fitness of
each strain i, fi, is then the product of individual epitope fitness
values Pn
a fa.
All infected cells Ii die at a rate dI due to reasons other than
immune killing (e.g. cytopathicity), and we assume that dIwdT.I n
addition, they are killed by the immune response at a rate
k~kmax=E  per day, where kmax is the maximal death rate of
infected cells due to CTL killing and E  is the number of CTLs in
the steady state in the absence of escape (see Table 1).
Furthermore, the strength of killing depends on how well the
viral strain is recognized by the immune system, and hence is
proportional to the number of CTLs specific for the particular
strain i, namely
P
a aiaEa. Likewise, the activation and production
of the effector sub-population Ea is proportional to the viral sub-
population recognized by this clone. The effector cells Ea are
produced at a constant rate s, are activated to proliferate at a
maximal rate g, and die at a rate dE.
The rates of new infections and CTL production are assumed to
obey Michaelis-Menten dynamics, which generates a saturation
effect in these terms similar to the Michaelis-Menten enzyme-
substrate kinetics [34,37,38]. By dividing the standard mass-action
term by the density of the cells that undergo such kinetics, one
generates more realistic and less oscillatory population dynamics of
virus/immune-system interactions. The terms describing target
cell depletion and the increase of infected cells saturate as a
function of the total of naive and infected CD4+ cells, reflecting
the T cell density-dependence of the transmission rate b [34].
Likewise, the proliferation via activation of the CTLs saturates as a
function of infected cells and effector cells reflecting a non-trivial
CTL kinetics in vivo, including competition for antigen and
saturation in killing [35,39,40]. The constant Ka is a dissociation
parameter, which is an inverse of the measure of sensitivity
(avidity; see below) of the effector T cell clone a: low Ka
corresponds to a sensitive clone, and high Ka corresponds to an
insensitive clone. By varying the distribution of the parameter Ka,
the immunodominance of an effector response is altered. The
Table 1. Assumed parameter values for HIV dynamics.
Parameter Assumed value Name & reference
l 2|107 cells/d Daily production of CD4+ target cells [31,55]
dT 0.01 d
{1 Natural death rate of naive CD4+ target cells [56,57]
maxbi{dI 1.5 d
{1 Initial replication rate of the viral population [58];
taken from SIV assays
k kmax=E  cell{1 d
{1; kmax~0:9d
{1 by default Assumes maximal CTL kill rate at 0.9 d
{1, and
otherwise ranged between 0.1 - 10 d
{1 [40,59,60]
dI 0.1 d
{1 Death rate of virus-infected cells not due to the CTL
killing; chosen such that the total HIV death rate is 1
d
{1 by default [61]
g 1.0 d
{1 Maximal proliferation rate of CD8+ cells [62]
Ka variable; rand(Kmin,Kmax) by default Distribution of dissociation rates; defines the
immunodominance pattern of the response
dE 0.01 d
{1 Death rate of CD8+ cells [63,64]
s=dE 103 cells Number of CD8+ cells of type a in the absence of
infection; chosen based on the assumption that CD8+
T cell clones increase w1000 -fold upon stimulation
[65]
n variable, 15 by default Number of targeted epitopes [66,67]
fmin variable, 0 by default minimal fitness due to single mutation [68]
m 3|10{5 Virus mutation rate per locus [69]
r variable; 3 by default Mean number of crossovers per genome [1,70]
pdb 0.1 Percentage of doubly infected cells [9,71]
doi:10.1371/journal.pone.0016052.t001
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in Table 1.
Mutation and recombination
Mutation and recombination are implemented as stochastic
events and are executed at discrete time steps during the
simulation. When new mutants and recombinants are generated,
the ancestral viruses are removed from the population of infected
cells, new strains are added, and the set of equations (2) is
restructured accordingly. Importantly, both mutation and recom-
bination do not alter the number of infected cells but only the
genetic composition of the provirus population.
In order to perform mutation, we approximate the number of
CD4+ cells infected with a single virus of type i between the time t
and tzDt as
DIi(t)~
biT(t)Ii(t)
1zT(t)z
Pm
k~1 Ik(t)
Dt: ð2Þ
This fraction undergoes mutation and is changed accordingly in
the population. The mutation step is carried out by assuming that
mutation occurs independently at every locus with probability m.
In order to perform recombination, we assume at every time-
point that (i) a fraction pdb of all infected cells is doubly infected, (ii)
amongst these doubly infected cells, the cells infected with two
different strains i and j occur at a frequency 2IiIj
  P
k Ik
   2,
which implies that the infection of a target cell by one virus strain
happens independently from infection of the same target cell by
another virus strain, (iii) a cell doubly infected with virus strains i
and j produces a new infection between the time t and tzDt with
the probability
(bizbj)
 
2
1zT(t)z
Pm
k~1 Ik(t)
T(t)Dt, ð3Þ
(iv) in the course of such infection event, strains i and j are
enclosed in the same viral capsule with the probability of 50%, and
that (v) the average number of crossover events is equal to r and
crossover-sites are randomly distributed across the viral genome.
Likewise, the newly recombined strains substitute the old strains in
the population of infected cells.
Measures
Escape types. We distinguish between two types of escape, E
and EC. The escape E is the escape which only carries a mutation
at the escape locus and regardless of the type of allele at the
compensatory locus; the escape EC is the escape which carries a
mutation at both escape locus and the compensatory locus (see
Fig. 1C). Unless mentioned which type of escape mutation is
analyzed, we refer to the E escape type.
Time of escape. The average time of escape of a mutant
with k escape mutations is measured by calculating the total
abundance of CD4+ cells infected with viruses with k escape
mutations and capturing the time when the number of these cells
exceeds 104.
Mean number of escapes. The mean number of escape
variants in the population at a given time is calculated by the mean
Hamming distance of the escape types from the wild type. For
example, in order to calculate the mean number of E escape
variants, we calculate the abundance of all strains with the number
of E escapes equal to zero, one, two, etc., then multiply each by its
Hamming distance from the wild type, and finally weight by the
total virus load.
CTL avidity. Each CTL clonal sub-population has its
assigned sensitivity (avidity) value Sa~max(Ka)=Ka, where Ka is
the Michaelis-Menten constant assigned to each clone. Thus, the
least sensitive population has mean avidity of 1. For each run
(unless mentioned otherwise), we randomly choose the Ka values
between Kmin and Kmax.
CTL diversity. The diversity of the CTL population is a
measure of their distribution. At each time point in one simulation
run we calculated the diversity of the CTL response by the use of
the Shannon diversity index 1z
P
i cilogc
  
i
.
log n ðÞ where ci is a
frequency of each CTL clone and n is the number of CTL clones.
The mean diversity was calculated by first averaging over all
simulations runs and then over time.
Results
The aim of this study was to examine the impact of
recombination on the immune escape of HIV. To that end, we
considered a deterministic, population dynamic model of HIV
infection with a stochastic implementation of mutation and
recombination [33–35], and examined the viral-immune dynamics
with and without recombination (see Methods). Using the model
we quantified the impact of recombination on a number of
important characteristics of the viral population (viral load,
emergence of escape, diversity, etc.) as well as a number of
important characteristics of the immune system (strength,
distribution of CTL clones, etc.).
Recombination accelerates the acquisition of escape
mutations
A key question is whether recombination can accelerate the
emergence of escape mutations in HIV, and if so, whether this is
beneficial for the virus. Fig. 2 shows two representative simulation
runs of the immune escape dynamics with and without
recombination. The figure shows the frequencies of escape
mutations at different epitope loci with three chosen escape
frequencies shown in colour. Fig. 2A shows an example of
dynamics where the impact of recombination is high. Fig. 2B
shows an example of dynamics where the impact of recombination
is low. This illustrates that recombination can, but does not
generally accelerate the emergence and the fixation of immune
escape. Furthermore, the distinct escape dynamics which can be
seen in both panels suggest that the characteristics of the immune
response play an important role in the scale of the recombination
impact, as will become evident in the next section. (Even though
the virus recombines with the same strength, the properties of not
only the virus but also the immune system lead to a much weaker
effect of recombination.)
In order to assess a general impact of recombination on the
evolution of escape in HIV, we measured the mean time of
appearance of escape mutations during infection. In particular, we
measured an average speed of accumulation of successive
mutations from the time point of infection, i.e. the average time
of appearance of a single mutant, the average time of appearance
of a double mutant, etc. The results are presented in Fig. 3 where
panel A shows the average times of appearance of successive E
escape mutants and panel B shows the average times of
appearance of successive EC escape mutants (see Methods and
Fig. 1C for an explanation of E and EC escape mutants).
The figure shows that in runs with recombination successive
escape variants appear faster than in the runs without recombina-
Recombination and Immune Escape of HIV
PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e16052tion, and that the accumulating effect of recombination increases
with the number of escape mutations. The impact of recombination
is even stronger for EC than for E escape types. Since EC escapes
need two point mutations, the results suggest that genetic shuffling
not only helps bringing together escape mutations from different
epitopes but also bringing together escape and compensatory
mutations at the same epitope (see Discussion). Thus, our model
shows that recombination accelerates the emergence of escape
variants by clustering togethervariousescapemutations inthe virus.
On the other hand, the acceleration of the emergence of escape
mutations is likely to have other consequences on the virus
dynamics, and thus we next examined which of the determinants
of the viral population are significantly affected by genetic
shuffling. We found that recombination has a considerable impact
on viral diversity as well as the average number of escape
mutations in the population. The results are shown in Fig. 4 where
the average over many stochastic simulation runs is considered.
Fig. 4A shows the viral genetic diversity as a function of time since
the beginning of infection. One can see that due to the faster
appearance of escape variants, a higher level of genetic diversity is
achieved in virus populations with recombination. Fig. 4B shows
the mean number of E escapes in the viral population as a function
of time (see Methods). The runs with recombination resulted in an
increased level of escape on the population scale early in the
infection, however after 2–3 years the same runs (rw0) showed
only a marginally higher number of escapes than the runs without
Figure 2. Example simulation runs of the virus escape dynamics. Simulation runs without recombination are shown with solid lines, and with
recombination with dashed lines. Plotted are frequencies of escapes at all n~15 loci as a function of time, and in each case three chosen loci are
printed in colour. Panel A shows an example simulation run for a parameter setting in which the impact of recombination is strong. Panel B shows an
example simulation run for a parameter setting in which the impact of recombination is weak. Recombination mostly, but not always, accelerates the
emergence and fixation of immune escapes. Parameters used in panel A: fmin~0:6, Kmin~0 Kmax~108, r~0. Parameters used in panel B: fmin~0:0,
Kmin~0 Kmax~5|109 r~1; the remaining parameters are the same and are defined in Table 1.
doi:10.1371/journal.pone.0016052.g002
Figure 3. The average times of appearance of successive accumulations of escape mutations. In both panels the time of emergence of
mutants with a given number of escape mutations is shown. Orange and blue bars correspond to runs with and without recombination, respectively.
A shows the time of appearance of E escapes (escapes at the escape locus). Panel B shows the time of appearance of EC escapes (escapes at the
escape and compensatory locus). The simulations show that recombination accelerates the emergence of escape mutations. Parameters used:
fmin~0, Kmin~0 Kmax~109; the others are defined in Table 1. The plot shows an average of 10000 simulation runs.
doi:10.1371/journal.pone.0016052.g003
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escapes occurred because of a high selective pressure to escape the
CTL responses, resulting in a subsequent decrease of the
stimulation of T cells and hence of the selective pressure. At the
same time, an increase in the mean number of escapes decreased
the fitness of the virus population, making it susceptible to the
invasion by strains with the wild-type allele (results not shown). As
a result, the escape epitopes became selected against during the
chronic stage of infection.
In line with this interpretation, we observed little or no reversion
to the wild-type in simulations where the cost of escape was low or
absent (results not shown). The higher mean number of escapes
with rw0 suggests that the process of selecting escape variants in
the primary phase of infection was accelerated by the mechanism
of recombination. Interestingly, we observed that recombination
had no significant effect on the viral load unless the process of
escape led to the appearance of an escape mutant with a
substantially decreased kill rate and a relatively high replicative
capacity (results not shown; see Discussion).
CTL dynamics and the impact of recombination
Several measures of the T cell response are used extensively in
immunological literature (e.g. immunodominance, breadth,
strength). However, using them to characterize the CTL dynamics
during a viral infection has the disadvantage that these measures
not only result from the properties of the immune cells but are are
strongly affected by the interactions of the immune response with
the virus and the stochastic effects. In order to characterize the
response itself, one could measure the avidity distribution of the T
cell population for a given antigen, but such quantification in
experimental assays remains not feasible. A mathematical model,
on the other hand, has the advantage that the sensitivity of each
CD8+ T cell clone to the wild-type virus is defined before the
simulation run (by the avidity value Sa; see Methods). Therefore,
in this study we propose to quantify the CTL response by the
mean avidity and the variance of avidity in each run. In this way,
(a) two independent variables are used to quantify the immune
response, while typical measures used in the literature can be read
off the plot, and (b) a correspondence between the measures of the
T cell population and the observed immune dynamics are
investigated.
The results are displayed in Fig. 5 where panel A shows the
diversity of the CTL response as a function of mean and variance
of the T cell avidity (see Methods) averaged over many simulations
(r~0 assumed but results for rw0 are qualitatively the same). As
expected, the diversity of the CTL response decreases (responses
become more even) as the variance of avidity decreases (low
diversity for low avidity occurs because all clones are equally
weak). However, increasing the mean avidity at a constant
variance (with the exception of the zero variance and the very
weak response) increases the evenness and hence the breadth of
the response. Thus we see that the relation between the avidity
and the breadth of the response can be non-trivial and counter-
intuitive.
Fig. 5B shows the mean number of escapes at the escape loci
after one year from infection, as a function of the mean and the
variance of avidity. Fig. 5C shows the factor of increase in the
measure in panel B due to recombination. One can see that as the
potency (mean avidity) of the immune response increases, the
efficiency of escape reaches an optimum, namely an initial increase
in the impact of recombination is followed by a decrease. The
initial increase occurs because with a higher avidity the strength of
the immune system increases and so does the selective pressure.
However, as explained above, by increasing the mean avidity the
hierarchy of the immune response changes yielding a broader
CTL response. Such immune response effectively targets the virus
at many loci, disabling the evasion of the immune system (escape
becomes too costly). However, at the same time that the immune
response broadens, the impact of recombination becomes
stronger. This is particularly evident for potent and non-
immunodominant CTL responses, i.e. for runs with high mean
and small variance in avidity. We see qualitatively the same
pattern when measuring the acceleration of the appearance of the
full escape mutant (Fig. 5D–F).
Why is the impact of recombination stronger for broader (non-
immunodominant) responses? The reason is that when all effector
responses are similarly strong, the expected time of escape at any
epitope will be comparable, meaning that all epitopes will escape
Figure 4. The effect of recombination on chosen parameters of the model. Orange and blue bars correspond to runs with and without
recombination, respectively. Panel A shows the viral diversity as a number of strains in the population (results for other measures of diversity were
qualitatively similar). It can be seen that recombination has a significant impact on diversity regardless of the stage of infection. Panel B shows the
mean number of escapes measured by the mean HD at the escape loci. The panel shows that recombination accelerates the evolution of immune
escape in the virus in the early phase of infection because it accelerates the acquisition of the escape mutations when they are beneficial. Note that
the strain with mutations at all loci (HD=30) has arisen only in the runs with recombination (one blue bar missing in panel B). The parameters are
identical as in Fig. 3 and the plot also shows an average of 10000 simulation runs.
doi:10.1371/journal.pone.0016052.g004
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advantageous at a similar time. A multiple number of escape
variants increasing in frequency will in turn allow for almost any
combination of those mutations to be advantageous too, possibly
outgrowing variants with a smaller number of escape epitopes.
This creates an environment in which genetic shuffling will have a
Figure 5. CTL dynamics and the impact of recombination. Figures are plotted as a function of mean avidity and variance of avidity of the CTL
response. Panel A shows the mean diversity of the CTL population which decreases with increasing mean (except for an initial increase in avidity) and
decreasing variance in avidity. Panel B shows the mean number of escapes during infection without recombination after 1 yr. of infection, which has
an optimum for a given mean avidity of response and correlates well with the diversity of the CTL response in panel A. Panel C shows the factor of
increase in the number of escapes after one year (cf. panel B) due to recombination, which is the strongest for broad and even responses. Panels D
and E show the time of appearance (days) of the full escape variant without and with recombination, respectively. The hatched areas show runs in
which the full escape mutant did not appear within the time of 1000 days. The impact of recombination on the time of emergence of the full escape
mutant, shown in panel F, corresponds well to the impact of recombination on the number of escape mutations after one year, shown in panel C. The
mean and variance of log avidities (M and V, respectively) plotted in all panels are defined in each simulation, and the distribution of avidity values is
drawn from a uniform distribution in each simulation run between M{
ﬃﬃﬃﬃﬃﬃﬃ
3V
p
and Mz
ﬃﬃﬃﬃﬃﬃﬃ
3V
p
. The parameters used: fmin~0, n~10, r~2. All other
parameters are given in Table 1. Each point in the plot shows an average of 5000 simulation runs.
doi:10.1371/journal.pone.0016052.g005
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favour different escape variants at different times, which will
decrease the diversity in the viral population, and hence the
variance which recombination can act on. This is why we see a
stronger impact of recombination on the number of escapes in
models with little or no immunodominance.
We also examined the impact of recombination for a decreased
cost of escape, and, in accordance with the intuition, we observed
an increased effect of recombination on the emergence of escapes
(results not shown). With decreasing cost of escape, the impact of
recombination on the emergence of escape variants increased
markedly. This is because fitter escape variants competed more
efficiently with the wild-type variants which in turn, by increasing
viral diversity, enhanced the impact of recombination. Finally, as
we observed that a decreased level of immunodominance is
generally associated with an increased breadth of the response and
also with an increased number of CD8+ cells, we conclude that
broader and stronger (higher activation and killing) immune
responses are likely to increase the impact of viral recombination
on the escape dynamics.
Discussion
In this study we show that recombination in HIV accelerates the
initial phase of viral coevolution with the immune system. We
demonstrate that random shuffling of the genetic material (a)
accelerates the emergence of escape mutations (both with and
without compensatory mutations), (b) increases viral diversity
during infection (in line with the experimental observations; see
[41]), (c) accelerates the acquisition of escape mutations in the
early stage of infection. Furthermore, our model exhibits a
negative correlation between the impact of recombination and the
efficiency of escaping the immune system. In particular, we
observe that the impact of recombination is strongest in broad,
non-immunodominant systems. Although our analysis focuses on
the escape from cytotoxic T-lymphocytes, similar effect might
occur with escape from other virus-specific responses including
antibodies.
Generally, we see a higher impact of recombination with than
without compensatory mutations, suggesting an acceleration in the
adaptation of the virus due to recombination in spite of positive
epistasis (a double mutant has higher fitness than a single mutant).
This may seem paradoxical as under positive epistasis, recombi-
nation may be expected to decelerate adaptation [42]. We see
three potential explanations for this paradox: (i) stochastic effects
in this model may override the effects of possible epistasis [11]; (ii)
the epistasis experienced by the virus is also influenced by the CTL
dynamics, and these could therefore outweigh the positive epistasis
of compensatory mutations with respect to reproductive fitness;
and (iii) more generally the model here is substantially more
complex than the population genetic models that have been used
to determine the mentioned effects of epistasis on recombination,
such that it is difficult to translate their observation to the situation
considered here.
Depending on the total fitness cost of escape, and thus also on
the number of escape loci, a mutant can arise that escapes at all
loci. Because such full escape is no longer controlled by the
immune response, the appearance of this mutant is accompanied
by a substantial increase in viral load. The time of appearance of
the full escape mutant depends strongly on the recombination rate.
However, whether such total escape ever occurs in late stage
patients is currently unclear.
Generally, we find that viral recombination increases the set-
point viral load. Given the moderate magnitude of this increase
(typically 5–10%, data not shown) and the large variance seen
between clinical measurements of the virus load, it is not an effect
that could easily be detected in clinical data even if there were
considerable variation in recombination rates between different
viral isolates. The fact that in our model recombination has only a
weak effect on virus load, however, is compatible with strong
selective pressures on escape mutants, as observed experimentally
[23,43–47], because large changes in viral fitness in vivo do not
necessarily induce substantial changes in virus load [48,49].
As common strains are likely to be targeted more strongly by the
immune response, a negative frequency dependent selection may
ensue, leading to potentially cyclical frequency dynamics between
the virus and the immune system. This behaviour shows a
resemblance with the so-called Red Queen dynamics in evolu-
tionary biology, where fluctuating selection in host-parasite
systems leads to allele frequency cycles and the maintenance of
genetic variants over long periods of time. One of the leading
hypothesis for the evolution of recombination (Red Queen
Hypothesis) states that such circumstances can explain the
evolutionary maintenance of genetic shuffling [50–52] (see [29]
for a review). Here, we have focused on examining the
consequences rather than the evolution of recombination rate.
Nevertheless, the fact that viral recombination accelerates the
acquisition of beneficial mutations in the virus indicates that
recombination, like in the Red Queen scenario, could be
advantageous for the virus. However, our model differs in a
number of ways from the typical Red Queen models (multiple loci,
absence of persistent allele fluctuations, interaction models, etc.),
and whether the observed benefit of recombination stems from the
similar effects as in the Red Queen Hypothesis is a topic that
warrants further investigation.
Although the primary aim of this study has been the impact of
recombination on the coevolution of HIV with the immune
system, the results presented here might shed light on the
evolutionary history of recombination in HIV (or other retrovi-
ruses like SIV). On the one hand, we have found that
recombination can have a strong impact on the speed of
acquisition of escape mutations, and thus arguably, on the
adaptation of the virus to the new hosts. This suggests that the
within-host selection acting on the virus might select for non-zero
recombination rates. On the other hand, the total viral load has
been correlated with the transmission probability of HIV, and
since we have seen that recombination moderately increases the
total virus load, the between-host selection acting on the viral
recombination is likely to be weak or zero. This also emphasizes
the importance of the within-host stage of evolution of HIV.
However, what evolutionary forces act on recombination and
how, as well as whether HIV had enough time to evolve its
recombination rate, remains a matter of discussion.
HIV and the immune system remain one of the best
qualitatively and quantitatively characterized coevolutionary
systems. However, a better insight into the coevolutionary
dynamics underlying the interaction of the virus with the immune
system, as well as into the population dynamical consequences of
recombination, requires an improved understanding of the
parameter space defining these interactions. First, the recently
underlined importance of macrophages in the development of
HIV infection [53] as well as of an increased recombination rate in
those cells [54] suggests that the inclusion of macrophages in a
model of recombination might qualitatively affect the outcome of
this study. Second, we have seen a positive correlation between the
number of crossover events in HIV and the mean number of
escape mutants in the late stage of infection (results not shown).
Therefore, a better understanding of the relation between viral
Recombination and Immune Escape of HIV
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phase of the infection might yield further insight into understand-
ing the optimal recombination rate in HIV. Third, our results
show that of particular importance is the estimation of the fitness
of escape mutants in the context of the immune system (in vivo).
The first component of this fitness is the cost that these mutations
induce in the absence of the immune response, which could be
measured by quantifying their effect on the replicative capacity of
HIV in vitro. The other component of the fitness in vivo reflects the
interaction of the virus and the immune response. This is
encapsulated by the parameter avidity, which describes both the
activation of the immune response by the virus as well as its
subsequent recognition and the killing by the immune system.
Obtaining more quantitative data on the specificity and diversity
of the T cell repertoire recognizing the virus would allow better
understanding of the effect of recombination on the population
dynamics of the virus, and more generally would enable
more quantitative approach to the causes underlying
immunodominance.
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